Evidence map›Paper›PMID 26063417›Full record

ArticleJournal of virology2015

Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques.

Ankita Chowdhury, Timothy L Hayes, Steven E Bosinger, Benton O Lawson, Thomas Vanderford, Joern E Schmitz, Mirko Paiardini, Michael Betts, Ann Chahroudi, Jacob D Estes and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 72 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. CD8Nature communications · 2023
    Article
  18. HTLV-1 Proliferation after CD8Microbiology spectrum · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Ankita ChowdhuryEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Timothy L HayesEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Steven E BosingerEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Benton O LawsonEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Thomas VanderfordEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Joern E SchmitzCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Mirko PaiardiniEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Michael BettsInstitute for Immunology and Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Ann ChahroudiEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Jacob D EstesAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory, Frederick, Maryland, USA.
Guido SilvestriEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA gsilves@emory.edu.
Emory University · USBeth Israel Deaconess Medical Center · USLeidos Biomedical Research Inc. (United States)University of Pennsylvania · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI ALTMAN, JOHN DAVID · 1985 to 2011
$114.0M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
Atlanta Pediatric Scholars ProgramK12HD072245 · NICHD · EMORY UNIVERSITY · PI Shari Barkin · 2012 to 2026
$5.5M
Mechanisms of SIV suppression by CD8+ lymphocytesR01AI090797 · NIAID · EMORY UNIVERSITY · PI SILVESTRI, GUIDO · 2010 to 2013
$3.2M
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENCRR NIH HHS P51 RR000165NCRR NIH HHS P51RR000165NIAID NIH HHS P30 AI050409NIAID NIH HHS R01 AI090797NIAID NIH HHS R01-AI090797NICHD NIH HHS K12 HD072245NIH HHS P51 OD011132NIH HHS P51OD011132
6 · The paper itself

Abstract

unlabelledNumerous studies have demonstrated that CD8(+) T lymphocytes suppress virus replication during human immunodeficiency virus (HIV)/simian immunodeficiency virus (SIV) infection. However, the mechanisms underlying this activity of T cells remain incompletely understood. Here, we conducted CD8(+) T lymphocyte depletion in 15 rhesus macaques (RMs) infected intravenously (i.v.) with SIVmac239. At day 70 postinfection, the animals (10 progressors with high viremia and 5 controllers with low viremia) were CD8 depleted by i.v. administration of the antibody M-T807R1. As expected, CD8 depletion resulted in increased virus replication, more prominently in controllers than progressors, which correlated inversely with predepletion viremia. Of note, the feature of CD8(+) T lymphocyte predepletion that correlated best with the increase in viremia postdepletion was the level of CD8(+) T-bet(+) lymphocytes. We next found that CD8 depletion resulted in a homogenous increase of SIV RNA in superficial and mesenteric lymph nodes, spleen, and the gastrointestinal tract of both controllers and progressors. Interestingly, the level of SIV DNA increased postdepletion in both CD4(+) central memory T lymphocytes (TCM) and CD4(+) effector memory T lymphocytes (TEM) in progressor RMs but decreased in the CD4(+) TCM of 4 out of 5 controllers. Finally, we found that CD8 depletion is associated with a greater increase in CD4(+) T lymphocyte activation (measured by Ki-67 expression) in controllers than in progressors. Overall, these data reveal a differential impact of CD8(+) T lymphocyte depletion between controller and progressor SIV-infected RMs, emphasizing the complexity of the in vivo antiviral role of CD8(+) T lymphocytes. IMPORTANCE: In this study, we further dissect the impact of CD8(+) T lymphocytes on HIV/SIV replication during SIV infection. CD8(+) T lymphocyte depletion leads to a relatively homogenous increase in viral replication in peripheral blood and tissues. CD8(+) T lymphocyte depletion resulted in a more prominent increase in viral loads and CD4(+) T lymphocyte activation in controllers than in progressors. Interestingly, we found T-bet expression on CD8(+) T lymphocytes to be the best predictor of viral load increase following depletion. The levels of SIV DNA increase postdepletion in both CD4(+) TCM and TEM in progressor RMs but decrease in the CD4(+) TCM of controllers. The findings described in this study provide key insights into the differential functions of CD8(+) T lymphocytes in controller and progressor RMs.

Indexed as

Lymphocyte DepletionAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDNA, ViralFemaleGastrointestinal TractImmunologic MemoryLymph NodesLymphocyte ActivationMacaca mulattaRNA, ViralSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusSpleenViral LoadDNA, ViralRNA, Viral

Identifiers

PMID26063417
PMCPMC4524088
OpenAlexW2097903253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.